360 papers
Biochemistry explores the intricate chemical processes that power life, bridging the gap between biology and chemistry to explain how molecules like proteins and DNA function within living cells. This field reveals the molecular machinery behind everything from metabolism to genetic inheritance, turning complex biological mysteries into understandable chemical interactions.
On Gist.Science, we bring you the freshest discoveries in this dynamic area directly from bioRxiv. Our team processes every new preprint uploaded to the server, transforming dense academic findings into both clear, plain-language overviews and detailed technical summaries. This dual approach ensures that whether you are a curious beginner or a seasoned researcher, you can grasp the significance of these breakthroughs immediately.
Below are the latest papers in biochemistry, complete with our curated summaries to help you navigate the cutting edge of molecular science.
This study reveals the structural basis for Rifamycin B's ability to inhibit rifampicin-resistant RNA polymerase, demonstrating that its unique C-4 O-carboxymethyl group forms a stabilizing salt bridge with the enzyme that bypasses common resistance mutations, thereby identifying a new target for rational antibiotic design.
This paper employs the murburn framework and quantitative modeling to demonstrate that hydrated extracellular polymeric phases, ranging from biofilms to birth, function as evolutionarily conserved, phase-separated matrices that regulate stochastic diffusible reactive species to enable oxygen utilization while maintaining biological coherence and facilitating complex life processes.
This study demonstrates that the Arg306 and Ser308 residues within the conserved RSSY motif of lipoyl synthase are critical for substrate binding and catalytic reactivity, with the S308C mutation specifically altering the auxiliary cluster's fate to produce a high-spin monothiolated intermediate and a desaturated byproduct instead of the normal lipoyl cofactor.
This study presents the first end-to-end hybrid quantum-classical pipeline that leverages latent vectors from a photonic quantum processor as structured priors for a generative adversarial network, successfully enhancing the de novo design of MHC-binding peptides with improved yield and broader sequence exploration, particularly for understudied alleles, as validated by both in silico predictions and in vitro experiments.
This study elucidates the structural and mechanistic basis of asymmetric transposon end recognition and pairing by the I-F3 CRISPR-associated transposase through cryo-EM analysis, revealing a novel protein-protein interface essential for high-fidelity transposition and offering insights for engineering gene therapy tools.
This paper introduces a novel method combining Deep Visual Proteomics with a modified extraction workflow that captures genomic DNA from flowthrough and peptides from the tip, enabling cell-type-resolved spatial proteogenomic analysis of matched genome and proteome data from archival FFPE tissue.
This study presents a novel, cost-effective platform called Coated Bacterial Enzymes (CBEs) that achieves one-step purification and immobilization of recombinant enzymes via SlpA domain fusion, resulting in a biocatalyst with enhanced stability, broader pH tolerance, and improved cation resistance compared to free enzymes.
This study reveals that Cathepsin C converts the lysosomal damage agent LLOMe into amyloid fibrils and, upon membrane rupture, utilizes its endogenous dipeptidyl ligase activity to perform the first fully endogenous, non-engineered proximity labeling within the lysosome, thereby uncovering new mechanisms of lysosomal perturbation and a novel tool for studying lysosomal biology.
This study demonstrates that the MRSA resistance enzyme PBP2a functions as an RNA-binding protein in vivo, where non-specific interactions with RNA transcripts via a cleft near its active site are essential for its full oxacillin resistance activity.
This study establishes that the cofactor-promiscuous HMGR enzyme in the Lyme disease pathogen *Borrelia burgdorferi* is essential for peptidoglycan synthesis and represents a promising antibacterial target, while also revealing a previously unrecognized evolutionary link between HMGR diversity and cofactor choice.